Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery (CALBLOC)
Calcium Chloride for Prevention of Blood Loss From Uterine Atony During Intrapartum Cesarean Delivery (CALBLOC): a Double Blind, Randomized, Placebo Controlled Trial and Nested Population Pharmacokinetic and Pharmacodynamic Analysis
Sponsor: Foundation for Anesthesia Education and Research
Listed as NCT05027048, this PHASE3 trial focuses on Cesarean Section Complications and Postpartum Hemorrhage and remains completed. Sponsored by Foundation for Anesthesia Education and Research, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Oct 2023 — Jul 2024 [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Feb 2023 — Oct 2023 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Mar 2022 — Feb 2023 [monthly]
Not Yet Recruiting PHASE3
▶ Show 1 earlier version
-
Sep 2021 — Mar 2022 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Foundation for Anesthesia Education and Research
- Society for Obstetric Anesthesia and Perinatology
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .